APO Research
Talk to an analyst

APO RESEARCH · REPORT

Interleukin 2 Receptor Subunit Alpha

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Interleukin 2 Receptor Subunit Alpha Industry Growth and Trends Forecast to 2032

26 December 202595 pages

Choose your research edition.

Industry ResearchInterleukin 2 Receptor Subunit Alpha Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Interleukin 2 Receptor Subunit Alpha Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Interleukin 2 Receptor Subunit Alpha Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interleukin 2 Receptor Subunit Alpha Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Interleukin 2 Receptor Subunit Alpha Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Interleukin 2 Receptor Subunit Alpha market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Interleukin 2 Receptor Subunit Alpha is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Interleukin 2 Receptor Subunit Alpha is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Interleukin 2 Receptor Subunit Alpha is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Interleukin 2 Receptor Subunit Alpha include AbbVie Inc., Philogen S.p.A., Mabtech Limited, APT Therapeutics, Inc. and Alkermes Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Interleukin 2 Receptor Subunit Alpha market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Interleukin 2 Receptor Subunit Alpha market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Interleukin 2 Receptor Subunit Alpha market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Interleukin 2 Receptor Subunit Alpha.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Interleukin 2 Receptor Subunit Alpha market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Interleukin 2 Receptor Subunit Alpha Market by Company

AbbVie Inc.

Philogen S.p.A.

Mabtech Limited

APT Therapeutics, Inc.

Alkermes Plc

Interleukin 2 Receptor Subunit Alpha Segment by Type

APT-602

DEL-106

MDNA-209

NKTR-358

Others

Interleukin 2 Receptor Subunit Alpha Segment by Application

Ovarian Cancer

Renal Cell Carcinoma

Blood Cancer

Autoimmune Disorders

Others

Interleukin 2 Receptor Subunit Alpha Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 2 Receptor Subunit Alpha market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interleukin 2 Receptor Subunit Alpha and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 2 Receptor Subunit Alpha.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Interleukin 2 Receptor Subunit Alpha manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Interleukin 2 Receptor Subunit Alpha in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of APT-602 Table 2. Major Company of DEL-106 Table 3. Major Company of MDNA-209 Table 4. Major Company of NKTR-358 Table 5. Major Company of Others Table 6. Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (W Units) Table 8. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Type (2021-2026) Table 9. Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (US$ Million) Table 10. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Type (2021-2026) Table 11. Global Interleukin 2 Receptor Subunit Alpha Price by Type (2021-2026) & (US$/Unit) Table 12. Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2027-2032) & (W Units) Table 13. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Type (2027-2032) Table 14. Global Interleukin 2 Receptor Subunit Alpha Sales by Type (2027-2032) & (US$ Million) Table 15. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Type (2027-2032) Table 16. Global Interleukin 2 Receptor Subunit Alpha Price by Type (2027-2032) & (US$/Unit) Table 17. North America Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (W Units) Table 18. North America Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (W Units) Table 20. Europe Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (W Units) Table 24. Latin America Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Type (2021-2026) & (US$ Million) Table 27. Interleukin 2 Receptor Subunit Alpha Industry Trends Table 28. Interleukin 2 Receptor Subunit Alpha Industry Drivers Table 29. Interleukin 2 Receptor Subunit Alpha Industry Opportunities and Challenges Table 30. Interleukin 2 Receptor Subunit Alpha Industry Restraints Table 31. Global Interleukin 2 Receptor Subunit Alpha Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Interleukin 2 Receptor Subunit Alpha Revenue Market Share by Company (2021-2026) Table 33. Global Interleukin 2 Receptor Subunit Alpha Sales by Company (2021-2026) & (W Units) Table 34. Global Interleukin 2 Receptor Subunit Alpha Sales Share by Company (2021-2026) Table 35. Global Interleukin 2 Receptor Subunit Alpha Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Interleukin 2 Receptor Subunit Alpha Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Interleukin 2 Receptor Subunit Alpha Major Company Production Sites and Headquarters Table 38. Global Interleukin 2 Receptor Subunit Alpha Company, Product Type & Application Table 39. Global Interleukin 2 Receptor Subunit Alpha Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Interleukin 2 Receptor Subunit Alpha by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Interleukin 2 Receptor Subunit Alpha Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Interleukin 2 Receptor Subunit Alpha Sales by Region (2021-2026) & (W Units) Table 44. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Region (2021-2026) Table 45. Global Interleukin 2 Receptor Subunit Alpha Sales by Region (2021-2026) & (US$ Million) Table 46. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Region (2021-2026) Table 47. Global Interleukin 2 Receptor Subunit Alpha Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Interleukin 2 Receptor Subunit Alpha Sales by Region (2027-2032) & (W Units) Table 49. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Region (2027-2032) Table 50. Global Interleukin 2 Receptor Subunit Alpha Sales by Region (2027-2032) & (US$ Million) Table 51. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Region (2027-2032) Table 52. Global Interleukin 2 Receptor Subunit Alpha Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (W Units) Table 55. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Application (2021-2026) Table 56. Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (US$ Million) Table 57. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Application (2021-2026) Table 58. Global Interleukin 2 Receptor Subunit Alpha Price by Application (2021-2026) & (US$/Unit) Table 59. Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2027-2032) & (W Units) Table 60. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Application (2027-2032) Table 61. Global Interleukin 2 Receptor Subunit Alpha Sales by Application (2027-2032) & (US$ Million) Table 62. Global Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Application (2027-2032) Table 63. Global Interleukin 2 Receptor Subunit Alpha Price by Application (2027-2032) & (US$/Unit) Table 64. North America Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (W Units) Table 65. North America Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (W Units) Table 67. Europe Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (W Units) Table 71. Latin America Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Application (2021-2026) & (US$ Million) Table 74. AbbVie Inc. Company Information Table 75. AbbVie Inc. Business Overview Table 76. AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 78. AbbVie Inc. Recent Development Table 79. Philogen S.p.A. Company Information Table 80. Philogen S.p.A. Business Overview Table 81. Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 83. Philogen S.p.A. Recent Development Table 84. Mabtech Limited Company Information Table 85. Mabtech Limited Business Overview Table 86. Mabtech Limited Interleukin 2 Receptor Subunit Alpha Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Mabtech Limited Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 88. Mabtech Limited Recent Development Table 89. APT Therapeutics, Inc. Company Information Table 90. APT Therapeutics, Inc. Business Overview Table 91. APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 93. APT Therapeutics, Inc. Recent Development Table 94. Alkermes Plc Company Information Table 95. Alkermes Plc Business Overview Table 96. Alkermes Plc Interleukin 2 Receptor Subunit Alpha Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Alkermes Plc Interleukin 2 Receptor Subunit Alpha Product Portfolio Table 98. Alkermes Plc Recent Development Table 99. North America Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 100. North America Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026) & (W Units) Table 101. North America Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2021-2026) Table 102. North America Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032) & (W Units) Table 103. North America Interleukin 2 Receptor Subunit Alpha Sales Market Share Forecast by Country (2027-2032) Table 104. North America Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Interleukin 2 Receptor Subunit Alpha Market Share by Country (2021-2026) Table 107. North America Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Interleukin 2 Receptor Subunit Alpha Market Share Forecast by Country (2027-2032) Table 109. Europe Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 110. Europe Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026) & (W Units) Table 111. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2021-2026) Table 112. Europe Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032) & (W Units) Table 113. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Interleukin 2 Receptor Subunit Alpha Market Share by Country (2021-2026) Table 117. Europe Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Interleukin 2 Receptor Subunit Alpha Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026) & (W Units) Table 121. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032) & (W Units) Table 123. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Share by Country (2021-2026) Table 127. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Share Forecast by Country (2027-2032) Table 129. Latin America Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Latin America Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026) & (W Units) Table 131. Latin America Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2021-2026) Table 132. Latin America Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032) & (W Units) Table 133. Latin America Interleukin 2 Receptor Subunit Alpha Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Interleukin 2 Receptor Subunit Alpha Market Share by Country (2021-2026) Table 137. Latin America Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Interleukin 2 Receptor Subunit Alpha Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026) & (W Units) Table 141. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032) & (W Units) Table 143. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Share by Country (2021-2026) Table 147. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Interleukin 2 Receptor Subunit Alpha Distributors List Table 152. Interleukin 2 Receptor Subunit Alpha Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Interleukin 2 Receptor Subunit Alpha Image Figure 2. Global Interleukin 2 Receptor Subunit Alpha Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Interleukin 2 Receptor Subunit Alpha Market Size (2021-2032) & (US$ Million) Figure 4. Global Interleukin 2 Receptor Subunit Alpha Sales (2021-2032) & (W Units) Figure 5. APT-602 Image Figure 6. Global APT-602 Sales YoY Growth (2021-2032) & (W Units) Figure 7. DEL-106 Image Figure 8. Global DEL-106 Sales YoY Growth (2021-2032) & (W Units) Figure 9. MDNA-209 Image Figure 10. Global MDNA-209 Sales YoY Growth (2021-2032) & (W Units) Figure 11. NKTR-358 Image Figure 12. Global NKTR-358 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Interleukin 2 Receptor Subunit Alpha Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Interleukin 2 Receptor Subunit Alpha Market Share by Type 2025 VS 2032 Figure 17. North America Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Type in 2025 Figure 18. North America Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Type in 2025 Figure 19. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Type in 2025 Figure 20. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Type in 2025 Figure 23. Latin America Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Interleukin 2 Receptor Subunit Alpha Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Ovarian Cancer Image Figure 30. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 31. Renal Cell Carcinoma Image Figure 32. Global Renal Cell Carcinoma Sales YoY Growth (2021-2032) & (W Units) Figure 33. Blood Cancer Image Figure 34. Global Blood Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 35. Autoimmune Disorders Image Figure 36. Global Autoimmune Disorders Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Interleukin 2 Receptor Subunit Alpha Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Interleukin 2 Receptor Subunit Alpha Market Share by Application 2025 VS 2032 Figure 41. North America Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Application in 2025 Figure 42. North America Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Application in 2025 Figure 43. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Application in 2025 Figure 44. Europe Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Application in 2025 Figure 47. Latin America Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Market Share in Value by Application in 2025 Figure 51. North America Interleukin 2 Receptor Subunit Alpha Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Interleukin 2 Receptor Subunit Alpha Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Interleukin 2 Receptor Subunit Alpha Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Interleukin 2 Receptor Subunit Alpha Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Interleukin 2 Receptor Subunit Alpha Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Interleukin 2 Receptor Subunit Alpha Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Interleukin 2 Receptor Subunit Alpha Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Interleukin 2 Receptor Subunit Alpha Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Interleukin 2 Receptor Subunit Alpha Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Interleukin 2 Receptor Subunit Alpha Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Interleukin 2 Receptor Subunit Alpha Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Interleukin 2 Receptor Subunit Alpha Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Interleukin 2 Receptor Subunit Alpha Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Interleukin 2 Receptor Subunit Alpha Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • APT-602
  • DEL-106
  • MDNA-209
  • NKTR-358
  • Others
Applications
  • Ovarian Cancer
  • Renal Cell Carcinoma
  • Blood Cancer
  • Autoimmune Disorders
  • Others
Companies covered
  • AbbVie Inc.
  • Philogen S.p.A.
  • Mabtech Limited
  • APT Therapeutics, Inc.
  • Alkermes Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Interleukin 2 Receptor Subunit Alpha Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Interleukin 2 Receptor Subunit Alpha Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Interleukin 2 Receptor Subunit Alpha Market by Type
  6. 1.3.1 APT-602
  7. 1.3.2 DEL-106
  8. 1.3.3 MDNA-209
  9. 1.3.4 NKTR-358
  10. 1.3.5 Others
  11. 1.4 Global Interleukin 2 Receptor Subunit Alpha Market Size by Type
  12. 1.4.1 Global Interleukin 2 Receptor Subunit Alpha Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Interleukin 2 Receptor Subunit Alpha Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Interleukin 2 Receptor Subunit Alpha Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Interleukin 2 Receptor Subunit Alpha Industry Trends
  2. 2.2 Interleukin 2 Receptor Subunit Alpha Industry Drivers
  3. 2.3 Interleukin 2 Receptor Subunit Alpha Industry Opportunities and Challenges
  4. 2.4 Interleukin 2 Receptor Subunit Alpha Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Interleukin 2 Receptor Subunit Alpha Revenue (2021-2026)
  2. 3.2 Global Top Players by Interleukin 2 Receptor Subunit Alpha Sales (2021-2026)
  3. 3.3 Global Top Players by Interleukin 2 Receptor Subunit Alpha Price (2021-2026)
  4. 3.4 Global Interleukin 2 Receptor Subunit Alpha Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Interleukin 2 Receptor Subunit Alpha Major Company Production Sites & Headquarters
  6. 3.6 Global Interleukin 2 Receptor Subunit Alpha Company, Product Type & Application
  7. 3.7 Global Interleukin 2 Receptor Subunit Alpha Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Interleukin 2 Receptor Subunit Alpha Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Interleukin 2 Receptor Subunit Alpha Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Interleukin 2 Receptor Subunit Alpha Tier 1, Tier 2, and Tier 3
4 Interleukin 2 Receptor Subunit Alpha Regional Status and Outlook
  1. 4.1 Global Interleukin 2 Receptor Subunit Alpha Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Interleukin 2 Receptor Subunit Alpha Historic Market Size by Region
  3. 4.2.1 Global Interleukin 2 Receptor Subunit Alpha Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Interleukin 2 Receptor Subunit Alpha Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Interleukin 2 Receptor Subunit Alpha Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Interleukin 2 Receptor Subunit Alpha Forecasted Market Size by Region
  7. 4.3.1 Global Interleukin 2 Receptor Subunit Alpha Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Interleukin 2 Receptor Subunit Alpha Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Interleukin 2 Receptor Subunit Alpha Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Interleukin 2 Receptor Subunit Alpha by Application
  1. 5.1 Interleukin 2 Receptor Subunit Alpha Market by Application
  2. 5.1.1 Ovarian Cancer
  3. 5.1.2 Renal Cell Carcinoma
  4. 5.1.3 Blood Cancer
  5. 5.1.4 Autoimmune Disorders
  6. 5.1.5 Others
  7. 5.2 Global Interleukin 2 Receptor Subunit Alpha Market Size by Application
  8. 5.2.1 Global Interleukin 2 Receptor Subunit Alpha Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Interleukin 2 Receptor Subunit Alpha Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Interleukin 2 Receptor Subunit Alpha Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AbbVie Inc.
  2. 6.1.1 AbbVie Inc. Company Information
  3. 6.1.2 AbbVie Inc. Business Overview
  4. 6.1.3 AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolio
  6. 6.1.5 AbbVie Inc. Recent Developments
  7. 6.2 Philogen S.p.A.
  8. 6.2.1 Philogen S.p.A. Company Information
  9. 6.2.2 Philogen S.p.A. Business Overview
  10. 6.2.3 Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Philogen S.p.A. Interleukin 2 Receptor Subunit Alpha Product Portfolio
  12. 6.2.5 Philogen S.p.A. Recent Developments
  13. 6.3 Mabtech Limited
  14. 6.3.1 Mabtech Limited Company Information
  15. 6.3.2 Mabtech Limited Business Overview
  16. 6.3.3 Mabtech Limited Interleukin 2 Receptor Subunit Alpha Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mabtech Limited Interleukin 2 Receptor Subunit Alpha Product Portfolio
  18. 6.3.5 Mabtech Limited Recent Developments
  19. 6.4 APT Therapeutics, Inc.
  20. 6.4.1 APT Therapeutics, Inc. Company Information
  21. 6.4.2 APT Therapeutics, Inc. Business Overview
  22. 6.4.3 APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 APT Therapeutics, Inc. Interleukin 2 Receptor Subunit Alpha Product Portfolio
  24. 6.4.5 APT Therapeutics, Inc. Recent Developments
  25. 6.5 Alkermes Plc
  26. 6.5.1 Alkermes Plc Company Information
  27. 6.5.2 Alkermes Plc Business Overview
  28. 6.5.3 Alkermes Plc Interleukin 2 Receptor Subunit Alpha Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Alkermes Plc Interleukin 2 Receptor Subunit Alpha Product Portfolio
  30. 6.5.5 Alkermes Plc Recent Developments
7 North America by Country
  1. 7.1 North America Interleukin 2 Receptor Subunit Alpha Sales by Country
  2. 7.1.1 North America Interleukin 2 Receptor Subunit Alpha Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026)
  4. 7.1.3 North America Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032)
  5. 7.2 North America Interleukin 2 Receptor Subunit Alpha Market Size by Country
  6. 7.2.1 North America Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026)
  8. 7.2.3 North America Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Interleukin 2 Receptor Subunit Alpha Sales by Country
  2. 8.1.1 Europe Interleukin 2 Receptor Subunit Alpha Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026)
  4. 8.1.3 Europe Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Interleukin 2 Receptor Subunit Alpha Market Size by Country
  6. 8.2.1 Europe Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026)
  8. 8.2.3 Europe Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales by Country
  2. 9.1.1 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Size by Country
  6. 9.2.1 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Interleukin 2 Receptor Subunit Alpha Sales by Country
  2. 10.1.1 South America Interleukin 2 Receptor Subunit Alpha Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026)
  4. 10.1.3 South America Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032)
  5. 10.2 South America Interleukin 2 Receptor Subunit Alpha Market Size by Country
  6. 10.2.1 South America Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026)
  8. 10.2.3 South America Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Country
  2. 11.1.1 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Size by Country
  6. 11.2.1 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Interleukin 2 Receptor Subunit Alpha Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Interleukin 2 Receptor Subunit Alpha Value Chain Analysis
  2. 12.1.1 Interleukin 2 Receptor Subunit Alpha Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Interleukin 2 Receptor Subunit Alpha Production Mode & Process
  7. 12.2 Interleukin 2 Receptor Subunit Alpha Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Interleukin 2 Receptor Subunit Alpha Distributors
  10. 12.2.3 Interleukin 2 Receptor Subunit Alpha Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst